Cardiac Intervention Advances: Robot-Assisted Mitral Procedure in U.S., AI Imaging Cleared

November 17, 2026
Latest company news about Cardiac Intervention Advances: Robot-Assisted Mitral Procedure in U.S., AI Imaging Cleared

November 17, 2026 — This week's cardiac device news centers on minimally invasive intervention: a robot-assisted valve procedure reached its first U.S. case, an AI-guided vascular imaging platform won FDA clearance, and a cath-lab imaging startup closed a large Series B round.

First U.S. Robot-Assisted Mitral Valve Replacement Procedure

Capstan Medical reported it has completed the first U.S. procedure with its robot-assisted transcatheter mitral valve replacement system, currently under development. The minimally invasive case was performed earlier this month at The Christ Hospital in Cincinnati, Ohio, as part of an early feasibility study in treating mitral regurgitation. The company's Compass system is designed to deliver the valve through a catheter rather than open surgery.

AI-Powered IVUS Imaging Platform Receives FDA Clearance

Evident Vascular received FDA 510(k) clearance for its Evident Vascular Guidance System and peripheral imaging catheters. The platform uses high-fidelity, AI-powered intravascular ultrasound (IVUS) to examine intravascular pathology during peripheral vascular interventions, giving operators real-time imaging inside the vessel.

Laza Medical Raises Up to $160M for Cath-Lab Imaging

Laza Medical closed a Series B round of up to USD 160 million, led by GE HealthCare, to advance its intelligent imaging system for the catheterization lab. The Los Gatos, California company says its first-of-a-kind system aims to expand access to high-quality cardiac care and lay the groundwork for future robotic interventions.

Other Notable Moves

  • Johnson & Johnson reported positive 30-day results from the FORWARD CAD IDE study of its Shockwave Javelin Coronary Intravascular Lithotripsy (IVL) catheter for calcified coronary disease.
  • Terumo lowered its full-year guidance after the RelayPro aortic product recall widened in scope, according to Citeline medtech coverage.

What it means

Across these announcements, the pattern is less about new standalone gadgets and more about how imaging, robotics and software fit into existing catheter and operating workflows. For suppliers of monitors, imaging accessories and intervention consumables, the underlying demand remains reliable hardware that works inside these clinical settings.

SaferLife Products Co., Ltd. supplies patient monitors, pulse oximeters and vital-signs accessories to distributors worldwide.